Nasdaq panel delists Aditxt, trading suspension set for June 25
Aditxt, Inc.
Aditxt, Inc. ADTX | 0.00 |
- Nasdaq hearings panel denied ADiTx’s request to remain listed, ordering delisting for failing minimum bid price and shareholder equity requirements.
- Trading suspension set for the open on June 25, 2026.
- Ignite Proteomics deal cited in the compliance plan: binding agreement with Copley Acquisition to merge Ignite at a $150 million valuation.
- Shareholder vote on the business combination scheduled for Sept. 14, 2026, with ADiTx targeting about a $125 million equity uplift.
- Special meeting set for July 23, 2026 to seek approval for a reverse stock split, aiming for a post-split price near $5.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADiTx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-071380), on June 24, 2026, and is solely responsible for the information contained therein.
